Skip to main content

Table 1 Standardized mean differences (SMD) for changes from baseline in the three treatment arms separately.

From: Spontaneous improvement in randomised clinical trials: meta-analysis of three-armed trials comparing no treatment, placebo and active intervention

 

No. of patients

No. of treatment arms

SMD (95% confidence interval)

I2 (%)

No treatment Overall

978

37

-0.24 (-0.36 to -0.12)

25

   Depression

42

3

-0.44 (-1.27 to 0.39)

70

   Nausea

60

2

-0.63 (-0.97 to -0.30)

0

   Pain – acute

63

5

-0.53 (-1.03 to -0.02)

49

   Pain – chronic

265

11

-0.10 (-0.27 to 0.06)

0

   Phobia

28

3

-0.39 (-0.91 to 0.12)

3

   Smoking

391

2

-0.40 (-0.54 to 0.26)

0

   Obesity

46

5

-0.02 (-0.41 to 0.36)

0

   Insomnia

83

6

0.03 (-0.27 to 0.33)

0

Placebo Overall

849

37

-0.44 (-0.61 to -0.28)

57

   Depression

44

3

-0.54 (-1.53 to 0.44)

80

   Nausea

59

2

-1.02 (-1.37 to -0.66)

0

   Pain – acute

62

5

-0.48 (-1.03 to 0.07)

57

   Pain – chronic

241

11

-0.32 (-0.59 to -0.04)

54

   Phobia

32

3

-0.85 (-1.35 to -0.36)

0

   Smoking

272

2

-0.58 (-1.37 to 0.22)

78

   Obesity

58

5

-0.17 (-0.52 to 0.18)

0

   Insomnia

81

6

-0.31 (-0.61 to 0.00)

0

Active treatment Overall

1073

52

-1.01 (-1.16 to -0.86)

57

   Depression

49

3

-1.27 (-1.91 to -0.62)

53

   Nausea

60

2

-1.39 (-2.58 to -0.23)

87

   Pain – acute

61

5

-2.12 (-3.01 to -1.24)

73

   Pain – chronic

373

17

-0.81 (-1.03 to -0.59)

52

   Phobia

48

5

-1.15 (-1.67 to -0.63)

33

   Smoking

275

3

-0.99 (-1.16 to -0.81)

0

   Obesity

61

5

-0.53 (-1.23 to 0.17)

73

   Insomnia

146

12

-1.06 (-1.30 to -0.82)

0